Tag: fibrogen

Glancy Prongay & Murray LLP, a National Class Action Law Firm, Continues Investigation of FibroGen Inc. (FGEN) on Behalf of Investors

LOS ANGELES, April 08, 2021 (GLOBE NEWSWIRE) — Glancy Prongay & Murray LLP (“GPM”), a national investor rights law firm, continues its investigation on behalf of FibroGen Inc. (“Fibrogen” or the “Company”) (NASDAQ: FGEN) investors concerning the Company and its officers’ possible violations of the federal securities laws. If you suffered a loss on your ….  Read More